Combination of anti-PD-1 inhibitors with radiotherapy for recurrent/metastatic squamous cell carcinoma in the head and neck region

被引：0
|
作者：
Tamaskovics, Balint [1 ]
Haussmann, Jan [1 ]
Neuwahl, Judith [1 ]
Jazmati, Danny [1 ]
Plettenberg, Christian [2 ]
Althaus, Laurenz [2 ]
Boelke, Edwin [1 ]
Matuschek, Christiane [1 ]
Budach, Wilfried [1 ]
机构：
[1] Univ Klinikum Dusseldorf, Klin Strahlentherapie & Radioonkol, Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Klin Hals Nasen Ohrenheilkunde, Dusseldorf, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P22-12
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [1] Duvelisib with docetaxel for patients with anti-PD-1 refractory, recurrent, or metastatic head and neck squamous cell carcinoma
    Hanna, Glenn J.
    Oakley, Liam B.
    Shi, Ruichao
    ONeill, Anne
    Shin, Kee-Young
    Sehgal, Kartik
    Dennis, Michael J.
    Jo, Vickie Y.
    Wong, Kristine S.
    Haddad, Robert I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma
    Hanna, Glenn J.
    Oakley, L. B.
    Shi, R.
    Oneill, A.
    Shin, K. Y.
    Scarfo, N.
    Sehgal, K.
    Dennis, M. J.
    Quinn, N.
    Jo, V. Y.
    Wong, K.
    Shvyrkova, A.
    Kushnarev, V.
    Shanthappa, B. U.
    Tkachuk, A.
    Kryukov, K.
    Sarachakov, A.
    Svekolkin, V.
    Lennerz, J.
    Waters, S.
    Haddad, R. I.
    CLINICAL CANCER RESEARCH, 2025, 31 (04) : 619 - 627
  • [3] Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
    Saada-Bouzid, E.
    Defaucheux, C.
    Karabajakian, A.
    Coloma, V. P.
    Servois, V.
    Paoletti, X.
    Even, C.
    Fayette, J.
    Guigay, J.
    Loirat, D.
    Peyrade, F.
    Alt, M.
    Gal, J.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1605 - 1611
  • [4] The impact of statin use on anti-PD-1 monotherapy for recurrent head and neck squamous cell carcinoma
    Kurukulasuriya, Chareeni
    Yassin-Kassab, Abdulkader
    Andrews, William
    Kane, Maureen
    Delgoffe, Greg
    Zandberg, Dan
    Scheff, Nicole
    Harbison, R. Alex
    Duvvuri, Umamaheswar
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
  • [5] Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck
    Humphries, Audrey
    Zhou, Connie J.
    Welsh, Madeleine
    Lem, Melinda
    Kang, Hyunseok
    Algazi, Alain P.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (02): : 321 - 327
  • [6] Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Chiu, Tai-Jan
    Huang, Tai-Lin
    Chien, Chih-Yen
    Huang, Wan-Ting
    Li, Shau-Hsuan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [7] REDUCED DENDRITIC CELL INFILTRATION IN ANTI-PD-1 RESISTANT HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Saito, Shin
    Shibata, Hirofumi
    Zhou, Liye
    Campbell, Katie
    Egloff, Ann Marie
    Uppaluri, Ravindra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A555 - A555
  • [8] A Phase 2 Clinical Trial of Pembrolizumab with Radiation Following Progression on anti-PD-1 Therapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Schoenfeld, J. D.
    Chen, Y. H.
    Gunasti, L.
    Droznin, A.
    Baginska, J.
    Nau, A.
    Weirather, J.
    Diaz, I. Gomez
    Margalit, D. N.
    Tishler, R. B.
    Fitzgerald, K. J.
    Mak, R. H.
    Uppaluri, R.
    Sehgal, K.
    Hanna, G. J.
    Haddad, R. I.
    So, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E32 - E32
  • [9] Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients
    Zandberg, Dan P.
    Zenkin, Serafettin
    Ak, Murat
    Mamindla, Priyadarshini
    Peddagangireddy, Vishal
    Hsieh, Ronan
    Anderson, Jennifer L.
    Delgoffe, Greg M.
    Menk, Ashely
    Skinner, Heath D.
    Duvvuri, Umamaheswar
    Ferris, Robert L.
    Colen, Rivka R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (01): : 129 - 138
  • [10] Impact of antibiotics on PD-1 inhibition in recurrent/metastatic head and neck squamous cell carcinoma
    Rabjerg, Helene Knap
    Eriksen, Jesper Grau
    Soby, Sebastian
    ORAL ONCOLOGY, 2024, 158
12345